Resolution Concerning 12 Years of Data Exclusivity for Biosimilars
The members of PILMA signed the following resolution to establish a regulatory pathway for biosimilars with 12 years of data exclusivity, in order to ensure affordable access to new treatments while encouraging labor job creation for the future. Click here to view the resolution. [su_note note_color=”#005086″ text_color=”#ffffff”] “More medicines are in the development pipeline in […]
Resolution Concerning Strong Intellectual Property Protections in the Trans-Pacific Partnership
The members of PILMA signed the following resolution concerning the need for strong intellectual property provisions in the Trans-Pacific Partnership trade pact in order to promote U.S. innovation and protect U.S. jobs. Click here to view the resolution. [su_note note_color=”#005086″ text_color=”#ffffff”] The pharmaceutical sector, an Intellectual-Property Intensive Industry, is a leader as an economic engine, […]